anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Problem Agitate Solution

Arc collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 26,550
Current window 22,681-22,710
Pages 885
Rows per page 30
Arc: Problem Agitate Solutionclear collectionreset all
18 30 60

Arc

22,681-22,710 of 26,550

filter-aware
10
This is a validation slide showing scientific credibility through peer-reviewed publication.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
11
The slide uses a human silhouette as a central anchor to map specific medical conditions to anatomical locations.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
12
Highlights clinical success in patients who failed or could not tolerate standard azole or IV Amphotericin B therapies.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
13
Includes a timeline of clinical events and longitudinal charts for Creatinine and Potassium levels.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
14
The slide highlights the limitations of current first-line azole treatments and identifies a specific patient sub-segment with high unmet need.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
03
Saba Capital Management | Activist Presentation Deck | 33 slidesSaba Capital Management | Activist Presentation Deck | 33 slides · Saba Capital
Activist deck Activist investor Beat · Problem1 hit
04
The slide uses a table format to contrast Saba's own governance standards with their activist interventions in other funds.Saba Capital Management | Activist Presentation Deck | 33 slides · Saba Capital
Activist deck Activist investor Beat · Problem1 hit
05
Saba Capital Management | Activist Presentation Deck | 33 slidesSaba Capital Management | Activist Presentation Deck | 33 slides · Saba Capital
Activist deck Activist investor Beat · Problem1 hit
06
The slide uses a quote from Axel Merk to contrast with the poor performance data.Saba Capital Management | Activist Presentation Deck | 33 slides · Saba Capital
Activist deck Activist investor Beat · ProblemLoop · Cost Of Inaction1 hit
07
The slide uses a historical time-series chart to establish the 'problem' of a persistent valuation discount.Saba Capital Management | Activist Presentation Deck | 33 slides · Saba Capital
Activist deck Activist investor Beat · AgitateLoop · Cost Of Inaction1 hit
08
The chart uses a dot-grid visualization where each square represents a CEF; red indicates worse discount, grey is ASA, and green is better.Saba Capital Management | Activist Presentation Deck | 33 slides · Saba Capital
Activist deck Activist investor Beat · AgitateLoop · Cost Of Inaction1 hit
09
The slide uses a screenshot of a blog post and highlights a specific paragraph to critique the target's stance.Saba Capital Management | Activist Presentation Deck | 33 slides · Saba Capital
Activist deck Activist investor Beat · AgitateLoop · Cost Of Inaction1 hit
10
Saba Capital Management | Activist Presentation Deck | 33 slidesSaba Capital Management | Activist Presentation Deck | 33 slides · Saba Capital
Activist deck Activist investor Beat · Agitate1 hit
11
Uses a side-by-side comparison of the company's stated position (left) and the activist's rebuttal (right).Saba Capital Management | Activist Presentation Deck | 33 slides · Saba Capital
Activist deck Activist investor Beat · Agitate1 hit
12
The slide uses an authoritative quote from an SEC official to challenge the legality of a poison pill.Saba Capital Management | Activist Presentation Deck | 33 slides · Saba Capital
Activist deck Activist investor Beat · Agitate1 hit
13
The slide uses a screenshot of an external article as evidence of the target's public stance.Saba Capital Management | Activist Presentation Deck | 33 slides · Saba Capital
Activist deck Activist investor Beat · Agitate1 hit
20
Saba Capital Management | Activist Presentation Deck | 33 slidesSaba Capital Management | Activist Presentation Deck | 33 slides · Saba Capital
Activist deck Activist investor Beat · Solution1 hit
21
Saba Capital Management | Activist Presentation Deck | 33 slidesSaba Capital Management | Activist Presentation Deck | 33 slides · Saba Capital
Activist deck Activist investor Beat · Solution1 hit
22
Saba Capital Management | Activist Presentation Deck | 33 slidesSaba Capital Management | Activist Presentation Deck | 33 slides · Saba Capital
Activist deck Activist investor Beat · Solution1 hit
23
Saba Capital Management | Activist Presentation Deck | 33 slidesSaba Capital Management | Activist Presentation Deck | 33 slides · Saba Capital
Activist deck Activist investor Beat · Solution1 hit
24
Saba Capital Management | Activist Presentation Deck | 33 slidesSaba Capital Management | Activist Presentation Deck | 33 slides · Saba Capital
Activist deck Activist investor Beat · Solution1 hit
25
The slide uses a list-based framework to present a menu of potential strategic actions.Saba Capital Management | Activist Presentation Deck | 33 slides · Saba Capital
Activist deck Activist investor Beat · Solution1 hit
04
This is a classic activist 'problem-solution' framing slide.Trian Partners | Activist Presentation Deck | 133 slides · Trian Partners
Activist deck Activist investor Beat · Problem (Identify pain)Loop · Logic Chain1 hit
05
Trian Partners | Activist Presentation Deck | 133 slidesTrian Partners | Activist Presentation Deck | 133 slides · Trian Partners
Activist deck Activist investor Beat · Problem (Identify pain)Loop · Logic Chain1 hit
06
Includes a performance chart comparing TSR before and after Trian's involvement.Trian Partners | Activist Presentation Deck | 133 slides · Trian Partners
Activist deck Activist investor Beat · Problem (Identify pain)Loop · Logic Chain1 hit
07
The slide uses a three-column structure to frame the problem (underperformance), the cause (board), and the solution (nominees).Trian Partners | Activist Presentation Deck | 133 slides · Trian Partners
Activist deck Activist investor Beat · Problem (Identify pain)Loop · Logic Chain1 hit
08
The slide uses a two-column layout to contrast operational structure with financial performance and strategic moat.Trian Partners | Activist Presentation Deck | 133 slides · Trian Partners
Activist deck Activist investor Beat · Problem (Identify pain)Loop · Logic Chain1 hit
09
The slide highlights a significant drop in profitability and cash flow despite massive capital investment.Trian Partners | Activist Presentation Deck | 133 slides · Trian Partners
Activist deck Activist investor Beat · Problem (Identify pain)Loop · Logic Chain1 hit
10
Uses a before-after-framing style to contrast high revenue with low margins.Trian Partners | Activist Presentation Deck | 133 slides · Trian Partners
Activist deck Activist investor Beat · Problem (Identify pain)Loop · Logic Chain1 hit
11
Uses a quote-contradiction framework to undermine management's narrative.Trian Partners | Activist Presentation Deck | 133 slides · Trian Partners
Activist deck Activist investor Beat · Problem (Identify pain)Loop · Logic Chain1 hit